금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
September Fed interest-rate increase is 'very unlikely,' Goldman Sachs says
"Very unlikely."...
US Dollar Index Price Forecast: Bears push against two-month lows at 99.40
The US Dollar Index (DXY) extends losses for the third consecutive day on Monday, with bears testing...
Fed rate hike bets retreat as markets await retail earnings and fresh economic signals: Dow Jones, S&P, Nasdaq, Wall Street Futures
U. S. stock futures were mixed on Monday as investors further reduced expectations for an interest r...
Forex Today: US Dollar softens as Fed caution meets improving US-Iran optimism
The US Dollar Index (DXY) trades with a softer tone near the 99.10 region as improving market sentiment reduces safe-haven demand for the Greenback.
Vanguard’s $94 Billion Mid Cap ETF Is Quietly Beating the S&P 500 With a Fifty Year Old Strategy
Most retirees who own an S&P 500 index fund hold a portfolio dominated by mega-cap technology, with mid-sized businesses getting almost no weight despite making up a meaningful share of corporate Amer ...
ProShares Equities for Rising Rates ETF reaches another all-time high
Leading AI chatbots produce inaccurate or biased results 90% of time on election topics: study
Super Hi outlines store expansion discipline while reporting Q1 revenue of RMB 226M
Vanguard S&P 500 ETF (VOO): Graham Stephan Likes This Index Fund
We just covered the Graham Stephan Stock Portfolio: Top 11 Stocks and Vanguard S&P 500 ETF (NYSE:VOO) ranks 7th on this list. Vanguard S&P 500 ETF (NYSE:VOO) is another index fund that Graham Stephan ...
Midwest listings site suspends its data feed to Zillow
Vanguard 500 Index Fund (VFIAX): Top Stock Pick by Graham Stephan
We just covered the Graham Stephan Stock Portfolio: Top 11 Stocks and Vanguard 500 Index Fund (NASDAQ:VFIAX) ranks 6th on this list. Vanguard 500 Index Fund (NASDAQ:VFIAX) is an index fund that Graham ...
Monashee Scales Back Its Bet on Structure Therapeutics
This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity.
Traders bet big on OpenAI beating Anthropic to IPO first
These 2 AI Giants Have Been Dormant. That’s Exactly Why They Might Surprise Investors
The AI trade has had favorites. NVIDIA, Microsoft, Alphabet, and Meta have carried the narrative, while two enterprise tech giants have quietly compounded earnings and built backlogs that few retail i ...
Ovintiv, California Resources raised to Buy at Citi; Devon Energy tapped as top pick